Bicyclic Peptide Makes Targeting EphA2 Possible.
Sign Up to like & getrecommendations! Published in 2021 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-nb2021-0393
Abstract: A tumor-penetrating bicyclic peptide that delivers a toxic payload may have finally unlocked the therapeutic potential of targeting EphA2. According to phase I trial data, BT5528 yielded clinical responses in three patients with ovarian and… read more here.
Keywords: makes targeting; peptide makes; bicyclic peptide; targeting epha2 ... See more keywords